Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Dtsch Med Wochenschr ; 138(3): 76-81, 2013 Jan.
Article in German | MEDLINE | ID: mdl-23299341

ABSTRACT

BACKGROUND: Measurements of plasma free metanephrines provide a sensitive test for the diagnosis of pheochromocytoma/paraganglioma (P/PGL), with highly elevated levels diagnostic of the disease. However, there is less diagnostic certainty in patients with mild elevations of these catecholamine metabolites. PATIENTS AND METHODS: Here we report use of the clonidine suppression test (CST) as a second-tier diagnostic test in 24 patients with mild elevations of plasma free metanephrines and/or catecholamines. Blood samples before and 3 hours after clonidine were analyzed for plasma concentrations of metanephrines and catecholamines with a negative test result defined as either a clonidine-induced fall in normetanephrine or noradrenaline by more than 40 % and 50 % respectively or to below the upper cut-offs of reference intervals. RESULTS: P/PGLs were confirmed in 9 patients and excluded in 15 by independent criteria. More than half of the patients without P/PGL showed normalized plasma concentrations of normetanephrine at baseline before clonidine compared to initial screening; all showed appropriate clonidine-induced falls in normetanephrine and noradrenaline or levels after the drug below upper cut-offs, indicating a diagnostic specificity of 100 % (CI 78-100 %). However, similar responses for noradrenaline were noted in 7 patients with P/PGL, indicating a diagnostic sensitivity of only 22 % (CI 2,8-60 %) compared to 100 % (CI 66-100 %) for normetanephrine. CONCLUSION: These results support use of the CST in combination with measurements of normetanephrine for confirming or excluding P/PGL in patients with borderline elevated test results, which should, however, first be confirmed by sampling blood under standardized resting conditions.


Subject(s)
Adrenal Gland Neoplasms/blood , Adrenal Gland Neoplasms/diagnosis , Clonidine , Normetanephrine/blood , Pheochromocytoma/blood , Pheochromocytoma/diagnosis , Adult , Aged , Biomarkers/blood , Female , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity
2.
Dtsch Med Wochenschr ; 128(38): 1941-6, 2003 Sep 19.
Article in German | MEDLINE | ID: mdl-14502445

ABSTRACT

BACKGROUND: The relationship between the various degrees of glucose tolerance and metabolic parameters have already been examined in various studies. Whether and to what extent the triglycerides (TG) affect other metabolic parameters in the different degrees of glucose tolerance is not certain. We therefore studied the importance of the triglycerides within a defined glycemic state in patients with an elevated familial risk for metabolic diseases. METHODS: We examined 866 patients (380 men, 486 women, mean age 44,4 years) in the "Familial Metabolic Syndrome Study" (FAMES). The patients were assigned to various degrees of glucose tolerance, according to the result of an oral glucose tolerance test. All degrees were divided into subgroups in respect of the triglyceride level (TG < 1,7 or TG >/= 1,7 mmol/l). In these subgroups we measured various metabolic parameters like fasting glucose, insulin resistance, insulin and proinsulin levels, HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), uric acid, HbA (1c), and free fatty acids (FFA). RESULTS: In patients with normal glucose tolerance the hypertriglyceridemia is already associated with other components of the metabolic syndrome like elevated HbA (1c), free fatty acids, proinsulin and insulin levels, worsened insulin sensitivity, elevated uric acid and LDL-C levels as well as a lowered HDL-C level. The patients with diabetes and hypertriglyceridemia also showed higher levels of FFA, proinsulin and insulin, a lower HDL-C level and a more prominent insulin resistance. CONCLUSION: Hypertriglyceridemia is an indicator for insulin resistance and elevated levels of other components of the metabolic syndrome within the various degrees of glucose tolerance.


Subject(s)
Blood Glucose/metabolism , Hypertriglyceridemia , Insulin Resistance , Metabolic Syndrome , Triglycerides/blood , Adult , Body Constitution , Body Mass Index , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Comorbidity , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/physiopathology , Female , Glucose Intolerance , Glucose Tolerance Test , Humans , Hypertriglyceridemia/blood , Hypertriglyceridemia/physiopathology , Insulin/blood , Male , Metabolic Syndrome/blood , Metabolic Syndrome/etiology , Metabolic Syndrome/genetics , Middle Aged , Risk Factors
3.
Eur J Intern Med ; 13(2): 108-114, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11893468

ABSTRACT

Background: The importance of insulin resistance in type 2 diabetes mellitus has been generally accepted. Only very few data about the degree of insulin resistance in a representative group of type 2 diabetic patients are available. The aim of this study was to ascertain the degree of insulin resistance and its relation to metabolic parameters in type 2 diabetic patients. Methods: We studied 96 type 2 diabetic patients. The inclusion criteria were type 2 diabetes according to WHO criteria and HbA(1c) between 6.8% and 10.5%. Insulin resistance was estimated in a euglycemic hyperinsulinemic clamp. Blood parameters like lipids, insulin, glucose, fatty acids, and leukocytes were also studied. Results: The insulin sensitivity of 71 of the type 2 diabetic patients was markedly lower than that of the controls. Twenty-five diabetic patients had an M(c) value within the range of the controls. The M(c) values, as a measure of insulin resistance, of the diabetic patients were between 0.3 and 5.2 mg/(kg min insulin), whereas the M(c) range of the controls was from 2.6 to 10.8 mg/(kg min insulin). Conclusions: Approximately 75% of the type 2 diabetic patients were insulin-resistant. Hence, type 2 diabetes mellitus was not equivalent to insulin resistance in every case.

4.
Appl Opt ; 40(21): 3483-94, 2001 Jul 20.
Article in English | MEDLINE | ID: mdl-18360373

ABSTRACT

A radiometrically stable, commercially available spectroradiometer was used in conjunction with a simple, custom-designed telescope to make spectrally continuous measurements of solar spectral transmittance and directly transmitted solar spectral irradiance. The wavelength range of the instrument is 350-2500 nm and the resolution is 3-11.7 nm. Laboratory radiometric calibrations show the instrument to be stable to better than 1.0% over a nine-month period. The instrument and telescope are highly portable, can be set up in a matter of minutes, and can be operated by one person. A method of absolute radiometric calibration that can be tied to published top-of-the-atmosphere (TOA) solar spectra in valid Langley channels as well as regions of strong molecular absorption is also presented. High-altitude Langley plot calibration experiments indicate that this technique is limited ultimately by the current uncertainties in the TOA solar spectra, approximately 2-3%. Example comparisons of measured and modtran-modeled direct solar irradiance show that the model can be parameterized to agree with measurements over the large majority of the wavelength range to the 3% level for the two example cases shown. Side-by-side comparisons with a filter-based solar radiometer are in excellent agreement, with a mean absolute difference of tau = 0.0036 for eight overlapping wavelengths over three experiment days.

SELECTION OF CITATIONS
SEARCH DETAIL
...